ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

McKesson To Purchase US Oncology

November 5, 2010

ASCO, NCCS Call For Oncology Center

September 13, 2002

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

NIH selects nine scientists for Pioneer Awards.

October 1, 2004

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

Komen Foundation Breast Cancer Awards

April 15, 1994